Your browser doesn't support javascript.
loading
Efficacy and safety of the fixed-ratio combination of insulin degludec and liraglutide by baseline glycated hemoglobin, body mass index and age in Japanese individuals with type 2 diabetes: A subgroup analysis of two phase III trials.
Komatsu, Mitsuhisa; Watada, Hirotaka; Kaneko, Shizuka; Ross Agner, Bue F; Nishida, Tomoyuki; Kaku, Kohei.
Afiliação
  • Komatsu M; Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, Shinshu University School of Medicine, Nagano, Japan.
  • Watada H; Department of Metabolism and Endocrinology, Juntendo University, Tokyo, Japan.
  • Kaneko S; Takatsuki Red Cross Hospital, Osaka, Japan.
  • Ross Agner BF; Novo Nordisk A/S, Søborg, Denmark.
  • Nishida T; Novo Nordisk Pharma Ltd., Tokyo, Japan.
  • Kaku K; Department of Internal Medicine, Kawasaki Medical School, Kurashiki, Japan.
J Diabetes Investig ; 12(9): 1610-1618, 2021 Sep.
Article em En | MEDLINE | ID: mdl-33595901
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicemia / Biomarcadores / Índice de Massa Corporal / Insulina de Ação Prolongada / Diabetes Mellitus Tipo 2 / Liraglutida / Hipoglicemiantes Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicemia / Biomarcadores / Índice de Massa Corporal / Insulina de Ação Prolongada / Diabetes Mellitus Tipo 2 / Liraglutida / Hipoglicemiantes Idioma: En Ano de publicação: 2021 Tipo de documento: Article